Showing 13 to 24 of 40 results


UK Woman Receives Pioneering Keyhole Breast Reconstruction
A 56-year-old British woman became the first in the UK to receive a new, less invasive keyhole breast reconstruction surgery, recovering in only one to two days with minimal pain, marking a significant advancement in breast cancer treatment.
UK Woman Receives Pioneering Keyhole Breast Reconstruction
A 56-year-old British woman became the first in the UK to receive a new, less invasive keyhole breast reconstruction surgery, recovering in only one to two days with minimal pain, marking a significant advancement in breast cancer treatment.
Progress
12% Bias Score


New Molecule Reduces Heart Tissue Necrosis, Promising Treatment for Heart Attacks
A joint Russian-Chinese team created a molecule reducing heart tissue necrosis, a leading global death cause, impacting over 700,000 Russians annually; initial testing shows promise, with clinical trials planned.
New Molecule Reduces Heart Tissue Necrosis, Promising Treatment for Heart Attacks
A joint Russian-Chinese team created a molecule reducing heart tissue necrosis, a leading global death cause, impacting over 700,000 Russians annually; initial testing shows promise, with clinical trials planned.
Progress
48% Bias Score


VA Research Budget Cuts Threaten Medical Innovation and Veteran Care
The U.S. Department of Veterans Affairs faces potential cuts to its nearly $1 billion medical research budget, threatening thousands of researchers and jeopardizing ongoing projects vital to veteran care and broader medical innovation, including a large genetic study of a million veterans.
VA Research Budget Cuts Threaten Medical Innovation and Veteran Care
The U.S. Department of Veterans Affairs faces potential cuts to its nearly $1 billion medical research budget, threatening thousands of researchers and jeopardizing ongoing projects vital to veteran care and broader medical innovation, including a large genetic study of a million veterans.
Progress
48% Bias Score


NICE Approves Robotic Surgery Systems for NHS
The National Institute for Health and Care Excellence (NICE) approved eleven robotic surgery systems for use in the NHS for the next three years, costing between £500,000-£1.5 million each, to improve surgical precision and patient outcomes, following a surge in use for bowel and orthopaedic procedu...
NICE Approves Robotic Surgery Systems for NHS
The National Institute for Health and Care Excellence (NICE) approved eleven robotic surgery systems for use in the NHS for the next three years, costing between £500,000-£1.5 million each, to improve surgical precision and patient outcomes, following a surge in use for bowel and orthopaedic procedu...
Progress
48% Bias Score


China's Toumai Robot Achieves Transcontinental Surgery
China's domestically developed Toumai surgical robot successfully completed a 12,000-kilometer remote surgery between Shanghai and Morocco, demonstrating the country's advancements in telemedicine and robotics, improving global access to specialized surgical care, with over 300 successful remote ope...
China's Toumai Robot Achieves Transcontinental Surgery
China's domestically developed Toumai surgical robot successfully completed a 12,000-kilometer remote surgery between Shanghai and Morocco, demonstrating the country's advancements in telemedicine and robotics, improving global access to specialized surgical care, with over 300 successful remote ope...
Progress
40% Bias Score


VR Headset Enables Writer with Severe Arm Injury to Continue Working
A 60-year-old writer with a severely injured right arm bought a £3,499 VR headset to continue working, highlighting VR's potential as an assistive technology, despite its high cost and potential for misuse.
VR Headset Enables Writer with Severe Arm Injury to Continue Working
A 60-year-old writer with a severely injured right arm bought a £3,499 VR headset to continue working, highlighting VR's potential as an assistive technology, despite its high cost and potential for misuse.
Progress
48% Bias Score

White Nights 2025" Oncology Forum: Global Collaboration for Cancer Care
The 11th St. Petersburg International Oncology Forum "White Nights 2025" will take place in St. Petersburg from July 2nd to 5th, 2025, bringing together oncologists from 29 countries to discuss advancements in cancer treatment and digital innovations, aiming to improve cancer care and reduce mortali...

White Nights 2025" Oncology Forum: Global Collaboration for Cancer Care
The 11th St. Petersburg International Oncology Forum "White Nights 2025" will take place in St. Petersburg from July 2nd to 5th, 2025, bringing together oncologists from 29 countries to discuss advancements in cancer treatment and digital innovations, aiming to improve cancer care and reduce mortali...
Progress
44% Bias Score

Trump Administration Threatens VA Medical Research With Massive Job Cuts
The Trump administration plans to cut over 70,000 jobs and numerous contracts from the Department of Veterans Affairs, threatening its crucial medical research despite recent congressional funding; researchers fear lifesaving projects will be scrapped, impacting both veterans and global medical inno...

Trump Administration Threatens VA Medical Research With Massive Job Cuts
The Trump administration plans to cut over 70,000 jobs and numerous contracts from the Department of Veterans Affairs, threatening its crucial medical research despite recent congressional funding; researchers fear lifesaving projects will be scrapped, impacting both veterans and global medical inno...
Progress
44% Bias Score

Bioresorbable Pacemaker Shows Promise for Post-Heart Surgery Recovery
Northwestern University researchers developed a temporary, bioresorbable pacemaker activated by near-infrared light, eliminating implanted electrodes, dissolving after days, and showing promise for faster post-operative recovery after heart surgery; tested in vivo on rats and dogs, and ex vivo on hu...

Bioresorbable Pacemaker Shows Promise for Post-Heart Surgery Recovery
Northwestern University researchers developed a temporary, bioresorbable pacemaker activated by near-infrared light, eliminating implanted electrodes, dissolving after days, and showing promise for faster post-operative recovery after heart surgery; tested in vivo on rats and dogs, and ex vivo on hu...
Progress
36% Bias Score

Bioresorbable, Light-Activated Pacemaker Revolutionizes Cardiac Treatment
Northwestern University researchers created a bioresorbable pacemaker smaller than a grain of rice, implantable via syringe, using light activation and powered by bodily fluids, addressing the needs of pediatric cardiac patients requiring temporary pacing.

Bioresorbable, Light-Activated Pacemaker Revolutionizes Cardiac Treatment
Northwestern University researchers created a bioresorbable pacemaker smaller than a grain of rice, implantable via syringe, using light activation and powered by bodily fluids, addressing the needs of pediatric cardiac patients requiring temporary pacing.
Progress
52% Bias Score

Successful Pulmonary Thromboaspiration Saves Pregnant Woman and Unborn Child
A 26-year-old woman at 29 weeks pregnant underwent a rare pulmonary thromboaspiration procedure at Turin's Molinette hospital due to a massive bilateral pulmonary embolism, successfully saving both her and her baby's lives thanks to a multidisciplinary team's expertise.

Successful Pulmonary Thromboaspiration Saves Pregnant Woman and Unborn Child
A 26-year-old woman at 29 weeks pregnant underwent a rare pulmonary thromboaspiration procedure at Turin's Molinette hospital due to a massive bilateral pulmonary embolism, successfully saving both her and her baby's lives thanks to a multidisciplinary team's expertise.
Progress
28% Bias Score

Drug Repositioning Offers Hope for Rare Disease Treatment
Professor Guillaume Canaud's successful repositioning of a cancer drug to treat Cloves syndrome, a rare disease, highlights the potential of drug repurposing to address the treatment gap for rare diseases, offering a faster and more cost-effective alternative to traditional drug development.

Drug Repositioning Offers Hope for Rare Disease Treatment
Professor Guillaume Canaud's successful repositioning of a cancer drug to treat Cloves syndrome, a rare disease, highlights the potential of drug repurposing to address the treatment gap for rare diseases, offering a faster and more cost-effective alternative to traditional drug development.
Progress
48% Bias Score
Showing 13 to 24 of 40 results